Deleted Tweets From Scott Gottlieb, R-D.C.

RT @DonnaYoungDC: #FDA is going to take new steps in 2018 to make the process for developing & approving #biosimilars more efficient; will… QT @DonnaYoungDC: #FDA Healthy Innovation, Safer Families: FDA's 2018 Strategic Policy Roadmap https://t.co/a8V7PGKncc #pharma… https://t.co/EmVQt2OqJO)

RT @FDA_Track: FDA acts to protect kids from serious risks of #opioid ingredients contained in some prescription cough and cold pr… https://t.co/tuJ7Nv7JjW

FDA requires safety labeling changes to limit the use of prescription opioid cough/cold medicines with codeine or hydrocodone in kids, warns about adult use: https://t.co/ppT3dJMEiT

New #FDA drug safety communication requires safety changes that make labeling for prescription opioid cough/cold medicines with codeine or hydrocodone used in children consistent with the labeling of other opioid-containing drugs: https://t.co/ppT3dJMEiT

#FDA takes new action to limit use of cold medicines for kids that contain codeine or hydrocodone, revises labeling for adult-only use because the serious risks of these medicines outweigh their potential benefits in vulnerable pediatric populations https

Yesterday, @NCIDirector Sharpless and I met to discuss ways the #FDA and @theNCI can make greater advances in the fight against cancer. #workingtogether https://t.co/8zzXh79SSt

RT @califf001: Bravo! i couldn't find an evidence based indication for opioids for cough & cold... These drugs got on the market before w… QT @SGottliebFDA: #FDA limits use of cough and cold medicines for kids that contain codeine or hydrocodone, and revises labeling for… https://t.co/YE0bRMqDb6)

RT @washingtonpost: FDA warns against giving kids cough and cold medicines with codeine or hydrocodone https://t.co/CFmVA4KwxS

RT @NCIDirector: Earlier today, my colleague @SGottliebFDA & I discussed how @theNCI & @US_FDA can find better ways to work together… https://t.co/lMlwOtI0bc

#FDA limits use of cough and cold medicines for kids that contain codeine or hydrocodone, and revises labeling for adult-only use. Finds serious risks that these medicines outweigh their potential benefits in vulnerable pediatric populations https://t.co/

About 3 out of 4 teens smokers will become adult smokers. We’re going to be taking new steps in 2018 to address adolescent and teen use of tobacco products https://t.co/o48I8OqGof

RT @NBCNews: Flu is "everywhere" as season hits peak, CDC says https://t.co/HAV1BQAc2Y https://t.co/p45RN5GbIl

(1/3) I want to thank @truthinitiative & @TobaccoFreeKids for sharing their thoughts at #FDA listening sessions this week on #FDA’s comprehensive plan on tobacco & nicotine regulation to improve lives of currently addicted cigarette smokers; prote

#FDA appreciates opportunity to hold these listening sessions with myself and FDA team; to get input from outside stakeholders with perspectives to share on the initiative we’ve fully committed to at #FDA to save lives by addressing addiction to nicotine

#FDA advanced our “Policy Roadmap” for 2018 which includes key new priorities on nutrition, biosimilar development, advancing gene therapy, promoting competition, and protecting families from addiction crises https://t.co/QHCwPDoCGx

(3/3) #FDA is committed to enabling input on our approach to tobacco and nicotine regulation. This process will be transparent. We’ll post to my public calendar groups that join our listening sessions; including public health groups, tobacco trade associa

@truthinitiative @TobaccoFreeKids (2/3) More #FDA listening sessions are upcoming w/other stakeholders; including industry, trade associations, and more public health groups. We’re gathering a range of viewpoints as we move forward with #FDA’s multi-year

RT @FDAOncology: Studies of outcomes in underrepresented subgroups are needed to inform real-world treatment decisions #RWE #EHRs… https://t.co/cWKeaKWDrf

RT @FDAOncology: Did you know FDA has a webpage for patients and a calendar of public meetings? https://t.co/nq7KW6G631

#FDA released a new, “2018 Policy Roadmap” that lays out some of the agency’s key policy objectives that we’ll pursue in the coming year https://t.co/1PSNbm5Xju

RT @DonnaYoungDC: #FDA is going to take new steps in 2018 to make the process for developing & approving #biosimilars more efficient; will… QT @DonnaYoungDC: #FDA Healthy Innovation, Safer Families: FDA's 2018 Strategic Policy Roadmap https://t.co/a8V7PGKncc #pharma… https://t.co/EmVQt2OqJO)

RT @FDA_Track: FDA acts to protect kids from serious risks of #opioid ingredients contained in some prescription cough and cold pr… https://t.co/tuJ7Nv7JjW

FDA requires safety labeling changes to limit the use of prescription opioid cough/cold medicines with codeine or hydrocodone in kids, warns about adult use: https://t.co/ppT3dJMEiT

New #FDA drug safety communication requires safety changes that make labeling for prescription opioid cough/cold medicines with codeine or hydrocodone used in children consistent with the labeling of other opioid-containing drugs: https://t.co/ppT3dJMEiT

#FDA takes new action to limit use of cold medicines for kids that contain codeine or hydrocodone, revises labeling for adult-only use because the serious risks of these medicines outweigh their potential benefits in vulnerable pediatric populations https

Yesterday, @NCIDirector Sharpless and I met to discuss ways the #FDA and @theNCI can make greater advances in the fight against cancer. #workingtogether https://t.co/8zzXh79SSt

RT @califf001: Bravo! i couldn't find an evidence based indication for opioids for cough & cold... These drugs got on the market before w… QT @SGottliebFDA: #FDA limits use of cough and cold medicines for kids that contain codeine or hydrocodone, and revises labeling for… https://t.co/YE0bRMqDb6)

RT @washingtonpost: FDA warns against giving kids cough and cold medicines with codeine or hydrocodone https://t.co/CFmVA4KwxS

RT @NCIDirector: Earlier today, my colleague @SGottliebFDA & I discussed how @theNCI & @US_FDA can find better ways to work together… https://t.co/lMlwOtI0bc

#FDA limits use of cough and cold medicines for kids that contain codeine or hydrocodone, and revises labeling for adult-only use. Finds serious risks that these medicines outweigh their potential benefits in vulnerable pediatric populations https://t.co/

About 3 out of 4 teens smokers will become adult smokers. We’re going to be taking new steps in 2018 to address adolescent and teen use of tobacco products https://t.co/o48I8OqGof

RT @NBCNews: Flu is "everywhere" as season hits peak, CDC says https://t.co/HAV1BQAc2Y https://t.co/p45RN5GbIl

(1/3) I want to thank @truthinitiative & @TobaccoFreeKids for sharing their thoughts at #FDA listening sessions this week on #FDA’s comprehensive plan on tobacco & nicotine regulation to improve lives of currently addicted cigarette smokers; prote

#FDA appreciates opportunity to hold these listening sessions with myself and FDA team; to get input from outside stakeholders with perspectives to share on the initiative we’ve fully committed to at #FDA to save lives by addressing addiction to nicotine

#FDA advanced our “Policy Roadmap” for 2018 which includes key new priorities on nutrition, biosimilar development, advancing gene therapy, promoting competition, and protecting families from addiction crises https://t.co/QHCwPDoCGx

(3/3) #FDA is committed to enabling input on our approach to tobacco and nicotine regulation. This process will be transparent. We’ll post to my public calendar groups that join our listening sessions; including public health groups, tobacco trade associa

@truthinitiative @TobaccoFreeKids (2/3) More #FDA listening sessions are upcoming w/other stakeholders; including industry, trade associations, and more public health groups. We’re gathering a range of viewpoints as we move forward with #FDA’s multi-year

RT @FDAOncology: Studies of outcomes in underrepresented subgroups are needed to inform real-world treatment decisions #RWE #EHRs… https://t.co/cWKeaKWDrf

RT @FDAOncology: Did you know FDA has a webpage for patients and a calendar of public meetings? https://t.co/nq7KW6G631

#FDA released a new, “2018 Policy Roadmap” that lays out some of the agency’s key policy objectives that we’ll pursue in the coming year https://t.co/1PSNbm5Xju